Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Diabetic Ketoacidosis in a Patient with Type 2 Diabetes After Initiation of Sodium-Glucose Cotransporter 2 Inhibitor Treatment
Heidi Storgaard, Jonatan I Bagger,
Filip K Knop
,
Tina Vilsbøll Lauritsen
,
Jørgen Rungby
Endocrinology and Metabolism
Department of Clinical Medicine
29
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Diabetic Ketoacidosis in a Patient with Type 2 Diabetes After Initiation of Sodium-Glucose Cotransporter 2 Inhibitor Treatment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
100%
Type 2 Diabetic Patients
100%
Diabetic Ketoacidosis
100%
Insulin
57%
Ketoacidosis
28%
Dizziness
14%
Diabetes
14%
Acute Disease
14%
Acidosis
14%
Ketonuria
14%
Reuptake
14%
Plasma Glucose
14%
Type 2 Diabetes Prevention
14%
Glucosuria
14%
Glucose-lowering Drugs
14%
Ketone Bodies
14%
Nausea
14%
Treatment Initiation
14%
Main Symptoms
14%
Male Patients
14%
Hypertensive
14%
Medicine and Dentistry
Sodium Glucose Cotransporter 2 Inhibitor
100%
Dapagliflozin
42%
Ketonuria
14%
Ketone Body
14%
Pharmacology, Toxicology and Pharmaceutical Science
Sodium Glucose Cotransporter 2 Inhibitor
100%
Dapagliflozin
42%
Ketonuria
14%